Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to low-dose bupivacaine for caudal block in children undergoing lower abdominal surgery
IRCT2017080513947N8Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and bupivacaine in postoperative pain, sponsored by Tabriz University of Medical Sciences. Primary endpoint: Duration of anesthesia in caudal block. Started Apr 2016; status: completed.
02
Drugs
dexmedetomidinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT2017080513947N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017080513947N8.